Q4 2025 Management View CEO Andrew Toy stated the company achieved "full year adjusted EBITDA profitability, delivered a well-controlled medical cost trend and reestablished market-leading membership ...

In 2025, both new and returning member cohort contribution profit performed in line with expectations. Returning member contribution profit remained strong at $200 PMPM year-over-year. New member ...

Q4 2025 earnings call recap: 2026 guidance, cost trends, contract exits, membership outlook, and breakeven EBITDA path—read now.

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.

The Department of the Treasury’s Office of Foreign Assets Control (OFAC) designated Sergey Sergeyevich ...

China's foreign aid strategy has shifted in the last few decades Now its model may be the one the U.S. is adopting even as China moves away from it.

For Bob Riney, president and CEO of Detroit-based Henry Ford Health, the high cost of healthcare is not a pricing problem — it reflects deeper structural flaws in the current financing system. “I ...

Positive economics is a fact-based analysis of what is occurring in an economy, without making prescriptions of what should or should not be happening.

This learning scenario reviews an essential public health concept and explains its importance to bioethics. Students are asked to think about how social determinants affect them a ...

The country’s medical system was already perpetually crisis-stricken along with the island’s economy, with lack of supplies, ...

In debates about the soaring costs of American health care, attention typically turns to insurance reform, pharmaceutical ...

Critics have questioned why the federal government should underwrite coverage costs for people with ACA health plans — but ...